Impact of long-acting reversible contraception on return for repeat abortion

American Journal of Obstetrics and Gynecology

Volumn 206, Issue 1, 2012, Pages 37.e1-37.e6

  Rose, Sally B ^a   Lawton, Beverley A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

copper multiload Cu375 intrauterine device; depot medroxyprogesterone acetate; levonorgestrel intrauterine system; long acting reversible contraception; repeat abortion

Indexed keywords

CONTRACEPTIVE AGENT; COPPER INTRAUTERINE DEVICE; LONG ACTING REVERSIBLE CONTRACEPTIVE; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; UNCLASSIFIED DRUG;

ABORTION; ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CONTRACEPTION; FEMALE; FOLLOW UP; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPEAT ABORTION; RISK FACTOR; SELF REPORT; SURVIVAL;

EID: 84455191830     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.06.102     Document Type: Article

References (27)

1. G.M. Secura, J.E. Allsworth, T. Madden, J.L. Mullersman, J. Peipert The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception Am J Obstet Gynecol 203 2010 115.e1 115.e7
2. P.D. Blumenthal, A. Voedisch, K. Gemzell-Danielsson Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception Hum Reprod Update 17 2011 121 137
3. J.J. Speidel, C.C. Harper, W.C. Shields The potential of long-acting reversible contraception to decrease unintended pregnancy Contraception 78 2008 197 200
4. American College of Obsetricians and Gynecologists Committee ACOG committee opinion no. 450: increasing use of contraceptive implants and intrauterine devices to reduce unintended pregnancy Obstet Gynecol 114 2009 1434 1438
5. National Collaborating Centre for Women's and Children's Health Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception Commissioned by the National Institute for Health and Clinical Excellence 2005 RCOG Press at the Royal College of Obstetricians and Gynaecologists London, UK
6. I. Mavranezouli Health economics of contraception Best Pract Res Clin Obstet Gynaecol 23 2009 187 198
7. World Health Organization Family and Reproductive Health Programme Medical eligibility criteria for contraceptive use 3rd ed. 2004 World Health Organization Geneva (Switzerland)
8. A. Chandra, G.M. Martinez, W.D. Mosher, J.C. Abma, J. Jones Fertility, family planning, and reproductive health of US women: data from the 2002 National Survey of Family Growth Natl Center Health Stat 23 2005 95
9. Guttmacher Institute Facts on contraceptive use, facts in brief 2008 Guttmacher Institute New York www.guttmacher.org/pubs/fb-contr-use.html 2008. Accessed Nov. 1, 2010
10. A. Brown Long-term contraceptives Best Pract Res Clin Obstet Gynaecol 24 2010 617 631
11. World Health Organization web site Selected practice recommendations for contraceptive use 2nd ed. 2004 World Health Organization, Department of Reproductive Health and Research Geneva (Switzerland) http://whqlibdoc.who.int/ publications/2004/9241562846.pdf Accessed Nov. 1, 2010
12. National Institute for Health and Clinical Excellence (NICE) CG30 Long-acting reversible contraception: NICE guideline, 2005 www.nice.org.uk/CG030 Accessed May 14, 2007
13. Sexual Health Scotland Giving You More Choice Campaign http://www.healthscotland.com/topics/health/wish/Giving-you-more-choice.aspx 2009 Accessed Nov. 5, 2010
14. H. Roberts, M. Silva, S. Xu Post abortion contraception and its effect on repeat abortions in Auckland, New Zealand Contraception 82 2010 260 265
15. T. Madden, C. Westhoff Rates of follow-up and repeat pregnancy in the 12 months after first-trimester induced abortion Obstet Gynecol 113 2009 663 668
16. O. Heikinheimo, M. Gissler, S. Suhonen Age, parity, history of abortion and contraceptive choices affect the risk of repeat abortion Contraception 78 2008 149 154
17. C. Schunmann, A. Glasier Specialist contraceptive counselling and provision after termination of pregnancy improves uptake of long-acting methods but does not prevent repeat abortion: a randomized trial Hum Reprod 21 2006 2296 2303
18. S. Goodman, S.K. Hendlish, M.F. Reeves, A. Foster-Rosales Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion Contraception 78 2008 143 148
19. S.B. Rose, B.A. Lawton, S.A. Brown Uptake and adherence to long-acting reversible contraception post-abortion Contraception 82 2010 345 353
20. New Zealand Health Information Service National Health Index Wellington (New Zealand): Ministry of Health www.nzhis.govt.nz/moh.nsf/pagesns/266?Open Accessed June 2, 2010
21. C. Salmond, P. Crampton, J. Aitkenson NZDep2006 index of deprivation User's manual 2007 Department of Public Health, University of Otago, Wellington, New Zealand Wellington (New Zealand) 1 16
22. C. Harvey, C. Seib, J. Lucke Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia Contraception 80 2009 527 532
23. A.B. Goldberg, L.H. Cardenas, A.E. Hubbard, P.D. Darney Post-abortion depot medroxyprogesterone acetate continuation rates: a randomized trial of cyclic estradiol Contraception 66 2002 215 220
24. G. Bachmann, P. Korner Bleeding patterns associated with non-oral hormonal contraceptives: a review of the literature Contraception 79 2009 247 258
25. T. Backman, S. Huhtala, R. Luoto, J. Tuominen, I. Rauramo, M. Koskenvuo Advance information improves user satisfaction with the levonorgestrel intrauterine system Obstet Gynecol 99 2002 608 613
26. D. Hubacher, N. Goco, B. Gonzalez, D. Taylor Factors affecting continuation rates of DMPA Contraception 60 1999 345 351
27. R.H. Allen, A.B. Goldberg, D.A. Grimes Expanding access to intrauterine contraception Am J Obstet Gynecol 201 2009 456.e1 456.e5